2025年6月24日 周二
首页 > 按月查看>2023年第4月 >363-368. DOI:10.20039/j.cnki.10073949.2023.04.012
PDF 导出
冠状动脉易损斑块的腔内影像学研究进展
作者:
作者单位:

(哈尔滨医科大学附属第二医院心血管内科,黑龙江省哈尔滨市 150001)

作者简介:

赵嘉伟,硕士研究生,研究方向为冠心病的临床与基础研究,E-mail:18845142201@163.com。通信作者于波,博士,主任医师,教授,博士研究生导师,研究方向为冠心病的临床与基础研究,E-mail:yubodr@163.com。

基金项目:

黑龙江省自然科学基金项目(TD2020H001)；国家自然科学基金重大仪器研制项目(81827806)


Imaging advances in the coronary vulnerable plaque
Author:
Affiliation:

Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献
    • |
  • 相似文献
    • | |
    摘要:

    冠状动脉易损斑块与冠状动脉粥样硬化性心脏病患者的不良心血管事件相关。腔内影像学的发展,为动脉粥样硬化斑块发生发展的生物学因素提供了新的视角。通过确定最有可能导致心血管不良事件发生的影像学特征,可以在临床上及时识别高危患者,并进行积极的防治,从而提高患者的生存质量。

    Abstract:

    Coronary vulnerable plaque is associated with adverse cardiovascular events in patients with coronary atherosclerotic heart disease. The development of intravascular imaging has provided a new perspective on the biological factors of the development of atherosclerotic plaques. By identifying the imaging features most likely to lead to adverse cardiovascular events, it can timely identify high-risk patients in clinic, and carry out active prevention and treatment, so as to improve the patients’ life quality.

    参考文献
    [1] 《中国心血管健康与疾病报告》编写组.《中国心血管健康与疾病报告2021》概述.中国心血管病研究, 2,0(7):577-596.THE WRITING TEAM OF CHINA CARDIOVASCULAR HEALTH AND DISEASE REPORT.Key points of report on cardiovascular health and diseases in China 2021.Chin J Cardiovasc Res, 2,0(7):577-596.
    [2] TOMANIAK M, KATAGIRI Y, MODOLO R, et al.Vulnerable plaques and patients:state-of-the-art.Eur Heart J, 0,1(31):2997-3004.
    [3] LIBBY P, PASTERKAMP G, CREA F, et al.Reassessing the mechanisms of acute coronary syndromes.Circ Res, 9,4(1):150-160.
    [4] CLARK D 3RD, PURI R S, NISSEN S E.Coronary atherosclerotic plaque progression:contributing factors in statin-treated patients.Expert Rev Cardiovasc Ther, 0,8(12):873-880.
    [5] MONTARELLO N J, NELSON A J, VERJANS J, et al.The role of intracoronary imaging in translational research.Cardiovasc Diagn Ther, 0,0(5):1480-1507.
    [6] LEISTNER D M, KRNKEL N, METEVA D, et al.Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap:results from the prospective translational OPTICO-ACS study.Eur Heart J, 0,1(37):3549-3560.
    [7] FRACASSI F, CREA F, SUGIYAMA T, et al.Healed culprit plaques in patients with acute coronary syndromes.J Am Coll Cardiol, 9,3(18):2253-2263.
    [8] 朱心忻, 乔虹.斑块侵蚀的诊疗进展.中国动脉硬化杂志, 2,0(7):628-632.ZHU X X, QIAO H.Progress in the diagnosis and treatment of plaque erosion.Chin J Arterioscler, 2,0(7):628-632.
    [9] LI B, LUO Y R, TIAN F, et al.Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes.Atherosclerosis, 0,0:10-18.
    [10] STONE G W, MAEHARA A, LANSKY A J, et al.A prospective natural-history study of coronary atherosclerosis.N Engl J Med, 1,4(3):226-235.
    [11] CALVERT P A, OBAID D R, O'SULLIVAN M, et al.Association between IVUS findings and adverse outcomes in patients with coronary artery disease:the VIVA (VH-IVUS in vulnerable atherosclerosis) study.JACC Cardiovasc Imaging, 1,4(8):894-901.
    [12] CHENG J M, GARCIA-GARCIA H M, DE BOER S P M, et al.In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome:results of the ATHEROREMO-IVUS study.Eur Heart J, 4,5(10):639-647.
    [13] ERLINGE D, MAEHARA A, BEN-YEHUDA O, et al.Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT Ⅱ):a prospective natural history study.Lancet, 1,7(10278):985-995.
    [14] LIU X L, SUN C B, TIAN J T, et al.Shrinkage as a potential mechanism of recurrent clinical events in patients with a large vulnerable plaque.J Cardiovasc Med (Hagerstown), 9,0(8):518-524.
    [15] SHISHIKURA D, KATAOKA Y, DI GIOVANNI G, et al.Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events.Eur Heart J, 0,1(31):2965-2973.
    [16] STONE P H, SAITO S, TAKAHASHI S, et al.Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics:the prediction study.Circulation, 2,6(2):172-181.
    [17] STONE P H, MAEHARA A, COSKUN A U, et al.Role of low endothelial shear stress and plaque characteristics in the prediction of nonculprit major adverse cardiac events:the PROSPECT study.JACC Cardiovasc Imaging, 8,1(3):462-471.
    [18] HOOGENDOORN A, KOK A M, HARTMAN E M J, et al.Multidirectional wall shear stress promotes advanced coronary plaque development:comparing five shear stress metrics.Cardiovasc Res, 0,6(6):1136-1146.
    [19] KOK A M, MOLONY D S, TIMMINS L H, et al.The influence of multidirectional shear stress on plaque progression and composition changes in human coronary arteries.EuroIntervention, 9,5(8):692-699.
    [20] SAFI H, BOURANTAS C V, RAMASAMY A, et al.Predictive value of the QFR in detecting vulnerable plaques in non-flow limiting lesions:a combined analysis of the PROSPECT and IBIS-4 study.Int J Cardiovasc Imaging, 0,6(6):993-1002.
    [21] JANG I K, TEARNEY G J, MACNEILL B, et al.In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography.Circulation, 5,1(12):1551-1555.
    [22] KUBO T K H, IMANISHI T, TAKARADA S, et al.Assessment of culprit lesion morphology in acute myocardial infarction:ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy.J Am Coll Cardiol, 7,0(10):933-939.
    [23] XING L, HIGUMA T, WANG Z, et al.Clinical significance of lipid-rich plaque detected by optical coherence tomography:a 4-year follow-up study.J Am Coll Cardiol, 7,9(20):2502-2513.
    [24] PRATI F, ROMAGNOLI E, GATTO L, et al.Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome:the CLIMA study.Eur Heart J, 0,1(3):383-391.
    [25] KENNEDY M W, FABRIS E, IJSSELMUIDEN A J, et al.Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non-culprit lesions to better predict adverse event outcomes in diabetes mellitus patients:COMBINE (OCT-FFR) prospective study.Rationale and design.Cardiovasc Diabetol, 6,5(1):144.
    [26] PINILLA-ECHEVERRI N, MEHTA S R, WANG J, et al.Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction:results from the COMPLETE trial optical coherence tomography substudys.Circ Cardiovasc Interv, 0,3(7):e008768.
    [27] FALK E, NAKANO M, BENTZON J F, et al.Update on acute coronary syndromes:the pathologists' view.Eur Heart J, 3,4(10):719-728.
    [28] DI VITO L, AGOZZINO M, MARCO V, et al.Identification and quantification of macrophage presence in coronary atherosclerotic plaques by optical coherence tomography.Eur Heart J Cardiovasc Imaging, 5,6(7):807-813.
    [29] PSALTIS P J, NICHOLLS S J.Imaging:focusing light on the vulnerable plaque.Nat Rev Cardiol, 6,3(5):253-255.
    [30] GATTO L, ALFONSO F, PAOLETTI G, et al.Relationship betweeen the amount and location of macrophages and clinical outcome:subanalysis of the CLIMA-study.Int J Cardiol, 2,6:8-12.
    [31] ABELA G S, KALAVAKUNTA J K, JANOUDI A, et al.Frequency of cholesterol crystals in culprit coronary artery aspirate during acute myocardial infarction and their relation to inflammation and myocardial injury.Am J Cardiol, 7,0(10):1699-1707.
    [32] DAI J N, TIAN J W, HOU J B, et al.Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome:an optical coherence tomography study.Atherosclerosis, 6,7:111-117.
    [33] TARUYA A, TANAKA A, NISHIGUCHI T, et al.Vasa vasorum restructuring in human atherosclerotic plaque vulnerability:a clinical optical coherence tomography study.J Am Coll Cardiol, 5,5(23):2469-2477.
    [34] NISHIMIYA K S E, YIN B W, PIAO Z L, et al.Micro-optical coherence tomography for endothelial cell visualization in the coronary arteries.JACC Cardiovasc Imaging, 9,2(9):1878-1880.
    [35] KATAOKA Y, PURI R S, ANDREWS J, et al.In vivo visualization of lipid coronary atheroma with intravascular near-infrared spectroscopy.Expert Rev Cardiovasc Ther, 7,5(10):775-785.
    [36] KARLSSON S, ANESTER E, FRANSSON K, et al.Intracoronary near-infrared spectroscopy and the risk of future cardiovascular events.Open Heart, 9,6(1):e000917.
    [37] OEMRAWSINGH R M, CHENG J M, GARCA-GARCA H M, et al.Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.J Am Coll Cardiol, 4,4(23):2510-2518.
    [38] WAKSMAN R, DI MARIO C, TORGUSON R, et al.Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging:a prospective, cohort study.Lancet, 9,4(10209):1629-1637.
    [39] BICCIR F G, BUDASSI S, OZAKI Y, et al.Optical coherence tomography-derived lipid core burden index and clinical outcomes:results from the CLIMA registry.Eur Heart J Cardiovasc Imaging, 2022:jeac110.
    引证文献
引用本文

赵嘉伟,吴天宇,于波.冠状动脉易损斑块的腔内影像学研究进展[J].中国动脉硬化杂志,2023,31(4):363~368.

复制
分享
文章指标
  • 点击次数:1191
  • 下载次数: 1972
历史
  • 收稿日期:2022-05-28
  • 最后修改日期:2022-11-22
  • 在线发布日期: 2023-04-06

您是本站第 4902662 访问者

邮编：421001 传真：0734-8160523

电话：0734-8160765 E-mail：dmzzbjb@163.net

中国动脉硬化杂志 ® 2025 网站版权所有